RZYLENCE
Dead / Abandoned — Abandoned — failure to respond (as of 01 Jun 2023)
What this means for you
This application is over — abandoned 12 May 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97386578
- Mark type
- Stylized text
- Filed
- 28 Apr 2022
- Abandoned
- 12 May 2023
- Attorney of record
- Maren C. Perry
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, wrinkles, hyperhydrosis, sports injuries, namely, injured or torn skin, muscle, ligaments, or bone, cerebral palsy, muscle spasms, muscle tremors and pain; pharmaceutical preparations, namely, peptide substrates for use in the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, sports injuries, namely, injured or torn skin, muscle, ligaments, or bone, cerebral palsy, muscle spasms, muscle tremors and pain; body creams, lotions and gels for medical purposes; eye creams, lotions and gels for medical purposes
Owner
- Revance Therapeutics, Inc., Nashville, TN, US
Prosecution history
- 02 Jun 2023 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 01 Jun 2023 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
- 01 Jun 2023 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 10 Feb 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 10 Feb 2023 — NON-FINAL ACTION E-MAILED
- 10 Feb 2023 — NON-FINAL ACTION WRITTEN
- 06 Feb 2023 — ASSIGNED TO EXAMINER
- 03 May 2022 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 02 May 2022 — NEW APPLICATION ENTERED